9% benzyl alcohol preservative to inhibit bacterial growth
Sales are restricted to research and laboratory use only not intended for human, veterinary, or any clinical application
Individuals on blood pressure medication should monitor their response carefully
Sun, K., Kusminski, C
In dietinduced obese mice, NNMTi treatment significantly reduced liver weight, liver volume, and hepatic triglyceride levels, alleviated hepatic steatosis and inflammatory infiltration, downregulated inflammatory factors (such as TNF and IL6) and lipogenic genes (such as FAS), and upregulated lipolytic genes (such as ATGL) in the liver
Contact their office in Pleasanton, California, to learn more about the benefits of injections